-
Bahrain announces Pfizer booster shots as Covid-19 cases rise globallyBahrain has become one of the first countries to offer the latest Pfizer XBB 1.5...
-
Early results for melanoma relapse vax promisingRIP to Mike Leach, a pioneering college football coach who died Monday evening following complications...
-
Bivalent vaccines for 18-49 age group to come later in 2022, as Singapore secures more supplies: Ong Ye KungSingapore plans to invite people aged between 18 and 49 to take their COVID-19 bivalent...
-
Study: Pfizer COVID pill showed no benefit in younger adultsPfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still...
-
Reckitt Benckiser, eyeing Pfizer OTC, carves out consumer health unit in reorganizationReckitt Benckiser, rumored to be eyeing a bid for Pfizer’s OTC unit, is making some...
-
Pfizer asks U.S. to authorize COVID pillU.S. pharmaceutical company Pfizer on Tuesday asked regulators to authorize its COVID pill after it...
-
WHO to set guidelines on COVID-19 antiviral pills soonWorld Health Organization (WHO) officials said on Friday (Nov 12) they were hoping to convene...
-
Pfizer asks US FDA to approve Covid-19 booster shots for all adultsPfizer asked US regulators on Tuesday to approve booster doses of its Covid-19 vaccine for...
-
Pfizer trials show its antiviral pill cuts risk of severe Covid-19 by 89%The makers of an antiviral pill for Covid-19 have said they stopped a trial after...